Amgen 2018 Layoffs

Discussion in 'Amgen' started by anonymous, May 8, 2018 at 9:52 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    A B C
     

  2. anonymous

    anonymous Guest

    does anyone know about the CAR group in building 15? I think they are a new group now but they I wanted to know if they have long term stability before trying to move into the group
     
  3. anonymous

    anonymous Guest

    Run the other way. Not a new group.. just leftovers after micromanager CAA gutted that group from people she didn’t like.. it’s pretty much yes people who will ship out of ATO any day.. on a whim
     
  4. anonymous

    anonymous Guest

    You always join Amgen Full Potential !
     
  5. anonymous

    anonymous Guest

    Expect same with Aimovig
     
  6. anonymous

    anonymous Guest

     
  7. anonymous

    anonymous Guest

    better hope the FAS team can continue implementing their sales skills with the workers
     
  8. anonymous

    anonymous Guest

    The lawsuit/price change should be eliminating this group soon.
     
  9. anonymous

    anonymous Guest

    Let’s hope so
     
  10. anonymous

    anonymous Guest

    Were screwed. We've no mortality benefit . Wait until managed care plans jump on this in first quarter . If were not preferred were in trouble. We can't spin class effect with no data to back it up. Layoffs are the least of our worries.
     
  11. anonymous

    anonymous Guest

    Has anyone with an inside scoop heard anything? Heard a new facility in ASF was in the works at some point, but more recently heard no decision has been made about a new facility in ASF yet...not sure if this could be related to accommodating potential downsizing from ATO site, particularly in research.
     
  12. anonymous

    anonymous Guest

    Thanks in advance to the poster above for responding to the potential new hire's question. So, I too am considering a move from another pharma co to Amgen and I get the whole idea that grass is not always greener on the other side concept. Is there still a concern of a potential layoff in 2019? If so, anticipated timeframe? What BU(s?) I would kindly appreciate if someone could clarify what product(s) a Red Team Senior Specialty Rep sells, how well those products are doing overall, and like most branded product issues, just a brief comment if there are a lot of managed care hurdles to jump daily to get scripts thru. Sorry to also ask, but what is an average base salary range for this position. Thanks again for the reply(ies.)
     
  13. anonymous

    anonymous Guest


    Where does Oncology blue team fit into the above? Do they also hire externally or usually only from within as a promotion?
     
  14. anonymous

    anonymous Guest

    Red Team is Repatha 90% and Corlanor remaining 10%. Repatha is still pretty brutal to sell hence the recent 60% price cut. Lots of turnover in this division. I would imagine this year has to go well or there has to be some kind of shake up.
     
  15. anonymous

    anonymous Guest


    Thank you to the poster above. Cardiology in general is a tough space to be in rn. Novartis is struggling w/ Entresto going into it’s fourth year and the jury is out as to when another round of layoffs will happen in that division. Repatha I’ve been told has been an uphill battle on both price and MC. I’m sure your CEO’s announcent to reduce it’s cost by 60% will help, but If the big nationally MC players are not covering it, the challenge still remains. Good luck to all of you selling Repatha. What is the salary range for Senior Specialty reps in this div? Thanks
     
  16. anonymous

    anonymous Guest

    Time to start a new thread - it's now 2019!
     
  17. anonymous

    anonymous Guest

    Salary ofcourse depends on where your coming in at. I would guess that you wouldn’t get much over 125k. No equity either when you sign on. Have to wait for end of first year for that.